CLINICAL_TRIALS
trial_result
· 2016-09-09
Clinical Trial Update: The Effects of RPL554 on Top of Standard COPD Reliever Medications [Phase 2]
Summary
Phase 2 trial update on the effects of RPL554 when added to standard COPD reliever medications; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Verona Pharma plc | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED